The Bill & Melinda Gates Foundation announced new investments to help advance access to mRNA research and vaccine manufacturing technology to support low- and middle-income countries’ (LMICs) capacity to develop vaccines at scale. mRNA technology is being leveraged for a range of infectious diseases, including tuberculosis, malaria, and Lassa fever, and has the potential to significantly lower the costs of mRNA research and manufacturing and enable expanded access. The foundation is in...